CST
CVS icon

Charles Schwab Trust’s CVS Health CVS Stock Holding History

Charles Schwab Trust’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$639K Buy
6,174
+40
+0.7% +$3.57K 0.04% 120
2026
Q1 		$441K Sell
6,134
-888
-13% -$68.4K 0.03% 117
2025
Q4 		$557K Buy
7,022
+488
+7% +$38.5K 0.04% 110
2025
Q3 		$493K Buy
6,534
+378
+6% +$25.9K 0.03% 121
2025
Q2 		$425K Buy
6,156
+100
+2% +$6.56K 0.03% 131
2025
Q1 		$410K Sell
6,056
-1,000
-14% -$59.8K 0.03% 124
2024
Q4 		$317K Sell
7,056
-2,064
-23% -$116K 0.03% 134
2024
Q3 		$573K Buy
9,120
+357
+4% +$20.8K 0.05% 107
2024
Q2 		$518K Buy
8,763
+88
+1% +$5.5K 0.05% 113
2024
Q1 		$692K Sell
8,675
-434
-5% -$33.2K 0.07% 95
2023
Q4 		$719K Sell
9,109
-382
-4% -$27.2K 0.07% 105
2023
Q3 		$663K Buy
9,491
+72
+0.8% +$5.1K 0.07% 109
2023
Q2 		$641K Sell
9,419
-1,340
-12% -$95.3K 0.08% 94
2023
Q1 		$800K Buy
10,759
+33
+0.3% +$2.77K 0.1% 88
2022
Q4 		$1,000K Buy
10,726
+1,706
+19% +$165K 0.13% 78
2022
Q3 		$860K Hold
9,020
– – 0.14% 78
2022
Q2 		$836K Buy
9,020
+37
+0.4% +$3.61K 0.17% 76
2022
Q1 		$909K Sell
8,983
-285
-3% -$29.9K 0.16% 77
2021
Q4 		$956K Sell
9,268
-101
-1% -$9.33K 0.16% 77
2021
Q3 		$795K Buy
9,369
+292
+3% +$24.5K 0.16% 99
2021
Q2 		$757K Sell
9,077
-16
-0.2% -$1.31K 0.15% 98
2021
Q1 		$676K Sell
9,093
-74
-0.8% -$5.39K 0.14% 98
2020
Q4 		$626K Hold
9,167
– – 0.15% 99
2020
Q3 		$535K Buy
9,167
+110
+1% +$6.84K 0.16% 93
2020
Q2 		$589K Buy
9,057
+3,074
+51% +$194K 0.2% 88
2020
Q1 		$355K Sell
5,983
-848
-12% -$56.6K 0.15% 102
2019
Q4 		$507K Sell
6,831
-60
-0.9% -$4.21K 0.2% 101
2019
Q3 		$430K Buy
+6,891
New +$408K 0.2% 91

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.99B AUM 86.33% 1-Year Est. Return

Charles Schwab Trust's CVS Position: Q2 2026 in Review

Charles Schwab Trust increased its CVS Health (CVS) stake by 0.65% in Q2 2026, buying an estimated $3.57K and bringing the position to 6,174 shares worth $639K. The position accounts for 0.04% of the portfolio, ranked #120.

Charles Schwab Trust first reported a position in CVS in Q3 2019 and has held it in 28 quarters since. The position peaked at $1,000K in Q4 2022. 403 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Charles Schwab Trust held 6,174 shares of CVS Health worth $639K as of Q2 2026.
  • Charles Schwab Trust bought 40 CVS Health shares in Q2 2026, an estimated $3.57K.
  • CVS Health made up 0.04% of Charles Schwab Trust's portfolio in Q2 2026, its #120 holding.
  • Charles Schwab Trust first reported a position in CVS Health in Q3 2019 and has held it in 28 quarters since.
  • Charles Schwab Trust's CVS Health position peaked at $1,000K in Q4 2022.
  • 403 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Charles Schwab Trust's 13F filing for Q2 2026, filed 10 Jul 2026.